Uridine diphosphate-dependent glycosyltransferase enzyme

Inventors

PHILIPPE, Ryan • KUMARAN, Ajikumar Parayil • Donald, Jason • PATEL, Krishna • Gupta, Swati • LIM, Ryan • Li, Liwei

Assignees

Manus Bio Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-12478082-B2

Patent

Publication Date

2025-11-25

Expiration Date


Abstract

The invention provides methods for making steviol glycosides, including RebM and glycosylation products that are minor products in stevia leaves, and provides enzymes, encoding polynucleotides, and host cells for use in these methods. The invention provides engineered enzymes and engineered host cells for producing steviol glycosylation products, such as RebM, at high purity and/or yield. The invention further provides methods of making products containing steviol glycosides, such as RebM, including food products, beverages, oral care products, sweeteners, and flavoring products.

Core Innovation

The disclosed invention concerns microbial production of rebaudioside M from rebaudioside D by culturing a host cell expressing a uridine diphosphate-dependent glycosyltransferase variant. The glycosyltransferase catalyzes 1-3′ glycosylation of rebaudioside D to rebaudioside M, including variants of SrUGT76G1 having specified amino acid modifications relative to a reference sequence; [procedural detail omitted for safety]. Host-cell genetic modifications also increase UDP-glucose availability to support steviol glycoside synthesis.

Production outcomes describe host strains that produce rebaudioside M with extracellular accumulation of the target product. Evaluations compare kaurene and steviol titers across pathway constructs alongside product signals for tested glycosyltransferase variants, with selected variants displaying higher activity than wild-type enzymes. The disclosure documents engineered microbial pathway modules, improved steviol-pathway performance, in vivo product formation, substrate-binding regions, and enhanced UDP-glucose availability.

Claims Coverage

The disclosure identifies three independent claims covering three inventive features directed to the production of rebaudioside M using engineered host cells.

Production of rebaudioside M using a glycosyltransferase variant

The claim covers culturing a host cell in the presence of rebaudioside D, wherein the host cell expresses a uridine diphosphate-dependent glycosyltransferase with at least 90% sequence identity to a reference sequence and designated amino acid substitution requirements; [procedural detail omitted for safety].

Production of rebaudioside M using an alanine-modified glycosyltransferase

The claim covers making rebaudioside M from rebaudioside D using a host cell expressing a glycosyltransferase having at least 90% sequence identity to a reference sequence, one or more specified amino acid modifications, and an alanine inserted or substituted at position 2 [procedural detail omitted for safety].

Production of rebaudioside M in a host cell modified for UDP-glucose availability

The claim covers making rebaudioside M from rebaudioside D using a host cell expressing a glycosyltransferase with specified amino acid modifications and containing genetic modifications that increase UDP-glucose availability [procedural detail omitted for safety].

Together, all elements of the claim across the independent claims define host-cell-based rebaudioside M production from rebaudioside D using specified glycosyltransferase variants and host modifications.

Stated Advantages

Selected SrUGT76G1 variants show substantially increased activity over wild type in steviol-glycoside conversion comparisons for the conversion of rebaudioside D to rebaudioside M.

The disclosure documents improved steviol-pathway performance in microbial pathway modules.

Documented Applications

Production of rebaudioside M from rebaudioside D using a host cell expressing a uridine diphosphate-dependent glycosyltransferase variant.

Formulations and applications in foods, beverages, oral care, and sweetener and flavoring products.

Microbial pathway-based rebaudioside M production, including documented in vivo production.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.